The U.S. Vaccination Rate Continues To Slow

The U.S. Vaccination Rate Continues To Slow

Up next

A chemical found in fish could help reinvent your sunscreen

It’s been over 25 years since the FDA approved a new ingredient for sunscreen in the United States. But a molecule called gadusol found in fish and coral reefs is a promising candidate. It absorbs U.V. rays — acting like a built-in sunscreen for fish. But there’s a big hurdle if ...  Show more

Should you be fibermaxxing? Here's what the science says

The average person eats 10-15 grams of fiber per day, according to the USDA. The problem? That’s WAY under the recommended daily amount. Fiber – a type of carb that our bodies are unable to digest – is prevalent in foods like fruits, veggies, whole grains, and beans. And it’s key ...  Show more

Recommended Episodes

Third Vaccine On The Way, Fauci Hails 'Spectacular Results'
Consider This from NPR

A third COVID-19 vaccine could receive emergency use authorization from the Food and Drug Administration this month. The vaccine made by Johnson & Johnson is 66% effective in preventing moderate to severe disease, according to a global study. Combined with the two vaccines curren ...  Show more

Why U.S. Vaccinations Started Slow And What We Know About The New Coronavirus Variant
Consider This from NPR

Initially, U.S. officials predicted that as many as 20 million Americans would be fully vaccinated before the end of 2020. And while that many vaccine doses were distributed, only a fraction of them have been administered. The federal government has given states control over dist ...  Show more

Why Are U.S. Coronavirus Cases Falling? And Will the Trend Last?
The Daily

The number of new coronavirus cases in the United States is falling, but has the country turned a corner in the pandemic? And what kind of threats do the new variants pose to people and to the vaccine rollout?

Today, we discuss the latest in the quest to stamp out the pa ...

  Show more

A Vaccine Breakthrough
The Daily

It’s a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.

But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine ...

  Show more